TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 78 filers reported holding TRICIDA INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,238 | -100.0% | 295,868 | +762.8% | 0.00% | -100.0% |
| Q3 2022 | $359,391,000 | +385.1% | 34,293 | +348.1% | 0.00% | – |
| Q2 2022 | $74,081,000 | +433.9% | 7,653 | +353.4% | 0.00% | – |
| Q1 2022 | $13,875,000 | +12867.3% | 1,688 | +7239.1% | 0.00% | – |
| Q3 2021 | $107,000 | -87.1% | 23 | -88.0% | 0.00% | – |
| Q2 2021 | $829,000 | -95.7% | 192 | -94.7% | 0.00% | – |
| Q1 2021 | $19,319,000 | -48.9% | 3,652 | -31.9% | 0.00% | – |
| Q4 2020 | $37,781,000 | -36.1% | 5,359 | -17.9% | 0.00% | – |
| Q3 2020 | $59,144,000 | +31.9% | 6,528 | +300.0% | 0.00% | – |
| Q2 2020 | $44,847,000 | -72.4% | 1,632 | -77.9% | 0.00% | – |
| Q1 2020 | $162,228,000 | +35.5% | 7,374 | +132.5% | 0.00% | – |
| Q4 2019 | $119,711,000 | -2.2% | 3,172 | -20.0% | 0.00% | – |
| Q3 2019 | $122,430,000 | +20.2% | 3,966 | +53.6% | 0.00% | – |
| Q2 2019 | $101,886,000 | -34.5% | 2,582 | -35.9% | 0.00% | – |
| Q1 2019 | $155,639,000 | +2661.5% | 4,030 | +1586.2% | 0.00% | – |
| Q4 2018 | $5,636,000 | -27.1% | 239 | -5.5% | 0.00% | – |
| Q3 2018 | $7,729,000 | – | 253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |